Effects of antitumor compounds isolated from Pteris semipinnata L on DNA topoisomerases and cell cycle of HL-60 cells

Acta Pharmacologica Sinica

Volumn 20, Issue 6, 1999, Pages 541-545

  Li, Jin Hua ^a   He, Cheng Wei ^a   Liang, Nian Ci ^a   Mo, Li Er ^b   Zhang, Xiao ^a  

^a Institute of Medical Biochemistry   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Antineoplastic agents; Cell cycle; Diterpenes; DNA topoisomerase; Drag synergism; Genistein; HL 60 cells; Pteris semipinnata L

Indexed keywords

11ALPHA HYDROXY 15 OXO KAUR 16 EN 19 OIC ACID; 7ALPHA 11ALPHA DIHYDROXY 15 OXO KAUR 16 EN 19 6BETA OLIDE; 7ALPHA 9 DIHYDROXY 15 OXO KAUR 16 EN 19 6BETA OLIDE; ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; HERBACEOUS AGENT; NATURAL PRODUCT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN HL 60; CONCENTRATION (PARAMETERS); DRUG CYTOTOXICITY; DRUG EFFECT; DRUG ISOLATION; DRUG POTENTIATION; DRUG STRUCTURE; ENZYME INHIBITION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL CYCLE; DNA TOPOISOMERASES, TYPE I; DNA TOPOISOMERASES, TYPE II; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; GENISTEIN; HL-60 CELLS; HUMANS;

EID: 0032966933     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ding HS. The Chinese Medicinal Crytogam. 1st ed. Shanghai; Shanghai Publishing House of Science and Technology; 1982. p 101.
2. Cui L, Liang NC, Chen ZD, Song ZJ. Studies on the anticancer effect and acute toxicity of Pteris semipinnata. J Chin Medicinal Materials 1996; 19: 29-32.
3. Zhang X, Cui L, Tanaka N, Liang NC. The active constituents and antitumor action of Pteris semipinnata. Chin Pharm J 1997; 32: 37-8.
4. Brown PO, Cozzarelli NP. A sign inversion mechanism for enzymatic supercoiling of DNA. Science 1979; 206: 1081-3.
5. Markovits J, Larsen AK, Segal-Bendirdjian E. Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives. Biochem Pharmacol 1951; 48: 519-60.
6. Bradfork MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-51.
7. Ellis AL, Altschuler E, Bales E, Hinds M, Mayes J, Soares L, et al. Phorbol regulation of topoisomerases I and II in human eukemia cells. Biochem Pharmacol 1994; 47: 387-96.
8. Hansen MB, Nielsen SE, Berg K. Reexamination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119: 203-10.
9. Wang JC. DNA topoisomerases. Annu Rev Biochem 1985; 51: 665-97.
10. Slichenmyer WJ, Rowinsky EK, Donehower RC, Kaufmann SH. The current status of camptothecin analogues as antitumor agents. J Natl Cancer Inst 1993; 85: 271-91.
11. Osheroff N. Biochemical basis for the interaction of type I and type II topoisomerase with DNA. Pharmacol Ther 1989; 41: 223-41.
12. Castrora FJ, Kelly WG. ATP inhibits nuclear and mitochon-drial type I topoisomerase from human leukemia cells. Proc Natl Acad Sic USA 1986; 83: 1680-4.
13. Markovits J, Lirassier C, Fosse P. Inhibitory effect of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II . Cancer Res 1989; 49: 5111-7.
14. Spinozzi F, Pagliaccl MC, Migliorati G. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in jurkat T-leukemia cells. Leuk Res 1991; 18: 431-9.
15. Hall IH, Lee KH, Mar EC. Antitunor agents, a proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. J Med Chem 1977; 20: 333-7.